冯宇雄医学院 | 浙江大学转化医学研究院基础医学· 肿瘤转移和抗药性的分子机制· “正常组织-肿瘤组织”3D共进化模型个人简介:冯宇雄，研究员，博士生导师工作单位：浙江大学转化医学研究院地址：浙江省杭州市江干区凯旋路268号中心大楼北楼联系方式：yxfeng@zju.edu.cn教育背景2004-2010    中科院上海生命科学研究院，生物化学与分子生物学专业，博士2000-2004    浙江大学生命科学学院，生物技术专业，本科 研究经历2018-现        浙江大学转化医学研究院/浙江大学附属第一医院，研究员/博士生导师2010-2017    麻省理工学院/Whitehead生物医学研究所，博士后代表性论文1.  Feng YX Jin DX Sokol ES Reinhardt F Miller DH Gupta PB. 2017. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1. Nature Communications 8:1079     2.  Sokol ES* Feng YX* Jin DX* Tizabi MD Miller DH et al. 2017. SMARCE1 is required for the invasive progression of in situ cancers. PNAS 114:4153-8 (*co-first author)  3.  Feng YX Sokol ES Del Vecchio CA Sanduja S Claessen JH et al. 2014. Epithelial-to-mesenchymal transition activates PERK-eIF2alpha and sensitizes cells to endoplasmic reticulum stress. Cancer Discovery 4:702-154.  Feng YX Sokol ES Gupta PB. 2014. The endoplasmic reticulum may be an Achilles heel of cancer cells that have undergone an epithelial-to-mesenchymal transition. Molecular & Cellular Oncology 1:e9618225.  Feng YX Wang T Deng YZ Yang P Li JJ et al. 2011. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology 53:483-926.  Feng YX Zhao JS Li JJ Wang T Cheng SQ et al. 2010. Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway. Hepatology 51:535-44已获专利“ER-stress inducing compounds and methods of use thereof” United States Patent 9316631 研究方向:1. 内质网应激反应通路在肿瘤转移和抗药性中的作用2. 新型抑制肿瘤转移的小分子化合物的筛选3. “正常组织-肿瘤组织”3D共进化模型的构建和临床应用发表文章:代表性论文1. Feng YX Jin DX Sokol ES Reinhardt F Miller DH Gupta PB. 2017. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1. Nature Communications 8:1079     2. Sokol ES* Feng YX* Jin DX* Tizabi MD Miller DH et al. 2017. SMARCE1 is required for the invasive progression of in situ cancers. PNAS 114:4153-8 (*co-first author)  3. Feng YX Sokol ES Del Vecchio CA Sanduja S Claessen JH et al. 2014. Epithelial-to-mesenchymal transition activates PERK-eIF2alpha and sensitizes cells to endoplasmic reticulum stress. Cancer Discovery 4:702-154. Feng YX Sokol ES Gupta PB. 2014. The endoplasmic reticulum may be an Achilles heel of cancer cells that have undergone an epithelial-to-mesenchymal transition. Molecular & Cellular Oncology 1:e9618225. Feng YX Wang T Deng YZ Yang P Li JJ et al. 2011. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology 53:483-926. Feng YX Zhao JS Li JJ Wang T Cheng SQ et al. 2010. Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway. Hepatology 51:535-44其他论文7. Gao X Lee HY da Rocha EL Zhang C Lu YF Li D Feng YX et al. 2016. TGF-beta inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors. Blood 128:2637-418. Wang T Xia L Ma S Qi X Li Q Xia Y Tang X Feng YX et al. 2016. Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal. Scientific Repo rts 6:251839. Sanduja S Feng Y Mathis RA Sokol ES Reinhardt F et al. 2016. AMPK promotes tolerance to Ras pathway inhibition by activating autophagy. Oncogene 35:5295-30310. Del Vecchio CA Feng Y Sokol ES Tillman EJ Sanduja S et al. 2014. De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling. PLoS biology 12:e100194511. Carmody LC Germain A Morgan B VerPlank L Fernandez C Feng Y et al. 2014. Identification of a Selective Small-Molecule Inhibitor of Breast Cancer Stem Cells-Probe 2. In Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD).12. Germain AR Carmody LC Nag PP Morgan B Verplank L Feng Y et al. 2013. Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. Bioorganic & Medicinal Chemistry Letters 23:1834-813. Germain AR Carmody LC Morgan B Fernandez C Forbeck E Feng Y et al. 2012. Identification of a selective small molecule inhibitor of breast cancer stem cells. Bioorganic & Medicinal Chemistry Letters 22:3571-414. Yang P Li QJ Feng Y Zhang Y Markowitz GJ et al. 2012. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22:291-30315. Shi S Deng YZ Zhao JS Ji XD Shi J Feng YX et al. 2012. RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway. The Journal of Biological Chemistry 287:7845-5816. Li G Ji XD Gao H Zhao JS Xu JF Sun ZJ Deng YZ Shi SFeng YX et al. 2012. EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. Nature Communications 3:66717. Ji XD Li G Feng YX Zhao JS Li JJ et al. 2011. EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration. Cancer Research 71:1156-6618. Wang T Hu HS Feng YX Shi J Li N et al. 2010. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. British Journal of Cancer 102:1618-26  荣誉与奖励:2018 入选第十四批国家“千人计划”青年项目 优先资助2015 美国Ludwig肿瘤研究基金博士后项目资助2009 “怡和”一等奖学金 中科院上海生命科学研究院2004 浙江省优秀毕业生，浙江大学优秀毕业生 ，中科院奖学金 